In a recent paper by Schmidt, et al., researchers have investigated the immunoregulatory effects of type 2 T helper (Th2) cells in an environment characterised by significantly high fat stores and malnutrition...
Uncategorized
Adaptations of tissue-resident memory T cells
In a recent paper by Crowl, et al., researchers provide novel insights into CD8+ tissue-resident memory T cells, describing how these cells adapt when present within specific environments, differing from one another...
Using lipid nanoparticles for cancer treatment
In a recent paper, Zhang, et al, have developed nanoparticles that can break down the barriers around tumours, reaching cancerous cells, providing a potentially improved and effective treatment for cancers...
A vaccine with a dual threat to cancer
In a recent paper, Badrinath and colleagues report of a vaccine designed to target one tumour immune escape mechanism...
Can BCG vaccination reduce mortality and morbidity from COVID-19?
In a recent paper, researchers looked at the affects of BCG vaccination of COVID-19 mortality and morbidity...
A potential new vaccine for rabies
In a recent paper, Callaway, et al., identified and described a potential new and improved rabies vaccine design. A groundbreaking effort by researchers...
Does cancer immunoediting occur in humans?
In a recent paper, researchers investigated whether humans are capable of undergoing natural cancer immunoediting during the course of cancer progression...
What happens to your cilia during SARS-CoV-2 infection?
In a recent paper, Fonseca, et al., sought out to describe the interaction between ORF10 and ZYG11B and determine whether it promotes the spread of SARS-CoV-2...
T cell lineage fate is driven by CD4 and CD8 co-receptor gene loci
Shinzawa and colleagues aimed to identify whether the fate of thymocyte lineage is determined by coreceptor gene loci that regulate TCR signal duration, or by coreceptor proteins, which determine TCR signal strength.
Novel insights: immunotherapy responses in lung cancer
In a recent paper, de Miguel-Perez, et al., have described, validated and tested a blood test that, for the first time, can be used as a liquid biopsy to predict a patient’s response to cancer immunotherapy and whether it will be successful or not...